FFAAIR presented research results on smoking cessation at ERS Congress 2022
EFA Member French Federation of Friends of Respiratory or Disabled Patients’ Associations (FFAAIR) submitted research on the “Barriers to early diagnosis...
Living with Allergy Association set sail for World Atopic Eczema Day
With chronic diseases such as atopic eczema (AE), patients often feel alone and helpless. The communication between the doctors and the patients weakens...
aha! Swiss Allergy Centre campaigned for World Atopic Eczema Day
EFA Member aha! Swiss Allergy Centre launched an awareness raising campaign for World Atopic Eczema Day, which took place throughout the week of 12 September....
aha! Swiss Allergy Center represented EFA at launch of Global Dermatology Coalition
EFA Partner GlobalSkin hosted an event with two non-state actors in official relations with the World Health Organization (WHO), the International League...
Allergy and Me seeks support to optimise website
EFA Member Allergy and Me, Serbia, is seeking support from the EFA network, partners and industry to improve their website through optimisation of existing...
EFA response to the European Commission proposal for a Regulation on Fluorinated Greenhouse Gases
After a consultative process which started in 2020, the European Commission published in June 2022 its proposal for a Regulation on Fluorinated Greenhouse...
PRESS RELEASE: Unite to recognise the many burdens of Atopic Eczema
September 14th 2022 - World Atopic Eczema Day 2022. Today, World Atopic Eczema Day, the patient communities across the globe join forces to raise awareness...
Joint Statement on the ongoing Energy Performance of Buildings Directive (EPBD) review
The European Federation of Allergy and Airways Diseases Patients’ Associations and the Federation of European Heating, Ventilation and Air Conditioning...
PRESS RELEASE: Europe reaches consensus on the burden of Atopic Dermatitis/Eczema
Milan, Italy – 7 September 2022. Following one year of in-depth discussions around the reality of Atopic Dermatitis/Eczema (AD/E), patients and doctors...
EFA at the first EU HERA Civil Society Forum
The European Commission organised the first meeting of the HERA Civil Society Forum, that took place in June online. EFA is a HERA official stakeholder....
EFA elected official stakeholder to the Health Emergency Preparedness and Response Authority civil society forum
EFA has been elected to participate in the civil society forum of the Health Emergency Preparedness and Response Authority (HERA), the newly established...
A tobacco-free future: EFA contributes to evaluation of the EU legislative framework for tobacco control
In recent months, the EU has launched several initiatives around tobacco policy and legislative frameworks, setting out the ambition for a ‘Tobacco-Free...
EU NCD Initiative: EFA analysis on prevention and chronic respiratory diseases
In a much-awaited launch, the European Commission presented on 22 June the final guidance document of the Healthier Together – EU NCD Initiative, the...
News Release: Global Dermatology Coalition Launched
25th May 2022 - Geneva
Today, a patient-led multi-stakeholder group of like-minded organizations – including dermatology patient organizations, health...
Health impacts of air pollution must be addressed in the EU Air Quality Directives Revision
In April, EFA participated in the second and last stakeholder meeting on the revision of the EU Air Quality Directives, organised by the European Commission’s...
EFA welcomes the EU’s Non-Communicable Diseases Initiative and contributes to the consultation
In December 2021, the European Commission launched the first effort in more than a decade to address the challenge of Non-Communicable Diseases (NCDs)...
The Health and Environmental Research Agenda for Europe reflects allergy and asthma needs
The EU-funded project ‘Integrating Environment and Health Research: a Vision for the EU’ brought together the World Health Organization (WHO), national...
European Medicines Agency starts new mandate on health crises preparedness
On 1 March 2022 entered into force the Regulation 2022/123 on the new extended mandate of the European Medicines Agency (EMA). Inspired by the learnings...
EFA offers EUPATI Fellow Training to Members – Express your interest today!
As part of our Capacity Building project, EFA will sponsor five allergy, asthma and/or chronic obstructive pulmonary disease (COPD) patients and patient...
Asthma + Lung UK advocates for lung patients facing rising living costs
Like many places in the world right now, living costs are rising sharply in the UK. This is particularly concerning for people with lung conditions who...